Drug intelligence / Profile preview

Haloeye Ultra

Development stage: Unknown
Lead developer: Eyekare Kilitch
Modality: Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Administration: Ophthalmic

Overview

Haloeye Ultra is a preservative-free artificial tear solution developed by Eyekare Kilitch for the management of dry eye disease and related ocular surface conditions. The formulation contains 0.3% w/v sodium hyaluronate, a naturally occurring biopolymer characterized by high visco-elasticity and water-binding capacity. It utilizes MDFP (Moisture Delivery Polymer Film) technology to ensure rapid tear film stabilization and prolonged lubrication of the ocular surface. Haloeye Ultra is indicated for conditions including chronic dry eye, digital eye strain, and post-operative recovery following LASIK or cataract surgery. By mimicking the behavior of natural tears, it provides a protective shield, restores tear film balance, and promotes the healing of the corneal epithelium.

Brand names: Haloeye Ultra
Other names: Sodium Hyaluronate Preservative Free Ophthalmic Solution

Targets

CD44 (CD44 antigen)

Beyond the preview

Go deeper on Haloeye Ultra.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Haloeye Ultra.

Explore the full profile